The presence of high levels of TGF‐β and α-SMA was correlated with liver fibrosis found in DOX treatment, implying that cirrhosis is an unfavorable impact of DOX during the suppression of HCC produced by DEN. The gene discussed is ACTA1; the disease is Cirrhosis.